|
1.
|
Chan GC, Chan WK and Sze DM: The effects
of beta-glucan on human immune and cancer cells. J Hematol Oncol.
2:252009. View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Tsoni SV and Brown GD: beta-Glucans and
dectin-1. Ann N Y Acad Sci. 1143:45–60. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Schmid F, Stone BA, McDougall BM, Bacic A,
Martin KL, Brownlee RT, Chai E and Seviour RJ: Structure of
epiglucan, a highly side-chain/branched (1→3;1→6)-β-glucan from the
micro fungus Epicoccum nigrum Ehrenb. ex Schlecht. Carbohydr
Res. 331:163–171. 2001.PubMed/NCBI
|
|
4.
|
Chen J and Seviour R: Medicinal importance
of fungal beta-(1→3),(1→6)-glucans. Mycol Res. 111:635–652.
2007.
|
|
5.
|
Rop O, Mlcek J and Jurikova T:
Beta-glucans in higher fungi and their health effects. Nutr Rev.
67:624–631. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Ariizumi K, Shen GL, Shikano S, Xu S,
Ritter R, Kumamoto T, Edelbaum D, Morita A, Bergstresser PR and
Takashima A: Identification of a novel, dendritic cell-associated
molecule, dectin-1, by subtractive cDNA cloning. J Biol Chem.
275:20157–20167. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Brown GD and Gordon S: Immune recognition.
A new receptor for beta-glucans. Nature. 413:36–37. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Ross GD: Regulation of the adhesion versus
cytotoxic functions of the Mac-1/CR3/alphaMbeta2-integrin
glycoprotein. Crit Rev Immunol. 20:197–222. 2000.PubMed/NCBI
|
|
9.
|
Lebron F, Vassallo R, Puri V and Limper
AH: Pneumocystis carinii cell wall beta-glucans initiate macrophage
inflammatory responses through NF-kappaB activation. J Biol Chem.
278:25001–25008. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Acton SL, Scherer PE, Lodish HF and
Krieger M: Expression cloning of SR-BI, a CD36-related class B
scavenger receptor. J Biol Chem. 269:21003–21009. 1994.PubMed/NCBI
|
|
11.
|
Rice PJ, Kelley JL, Kogan G, Ensley HE,
Kalbfleisch JH, Browder IW and Williams DL: Human monocyte
scavenger receptors are pattern recognition receptors for
(1→3)-beta-D-glucans. J Leukoc Biol. 72:140–146. 2002.
|
|
12.
|
Zimmerman JW, Lindermuth J, Fish PA,
Palace GP, Stevenson TT and DeMong DE: A novel
carbohydrate-glycosphingolipid interaction between a
beta-(1-3)-glucan immunomodulator, PGG-glucan, and lactosylceramide
of human leukocytes. J Biol Chem. 273:22014–22020. 1998. View Article : Google Scholar
|
|
13.
|
Vetvicka V and Yvin JC: Effects of marine
beta-1,3 glucan on immune reactions. Int Immunopharmacol.
4:721–730. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Mizuno M, Minato K, Ito H, Kawade M, Terai
H and Tsuchida H: Anti-tumor polysaccharide from the mycelium of
liquid-cultured Agaricus blazei mill. Biochem Mol Biol Int.
47:707–714. 1999.PubMed/NCBI
|
|
15.
|
Cheung NK and Modak S: Oral
(1→3),(1→4)-beta-D-glucan synergizes with antiganglioside GD2
monoclonal antibody 3F8 in the therapy of neuroblastoma. Clin
Cancer Res. 8:1217–1223. 2002.
|
|
16.
|
Zhang M, Chiu LC, Cheung PC and Ooi VE:
Growth-inhibitory effects of a β-glucan from the mycelium of
Poria cocos on human breast carcinoma MCF-7 cells:
Cell-cycle arrest and apoptosis induction. Oncol Rep. 15:637–643.
2006.
|
|
17.
|
Kimura Y, Sumiyoshi M, Suzuki T and
Sakanaka M: Antitumor and antimetastatic activity of a novel
water-soluble low molecular weight beta-1, 3-D-glucan (branch
beta-1,6) isolated from Aureobasidium pullulans 1A1 strain
black yeast. Anticancer Res. 26:4131–4141. 2006.PubMed/NCBI
|
|
18.
|
Ikewaki N, Fujii N, Onaka T, Ikewaki S and
Inoko H: Immunological actions of Sophy beta-glucan (beta-1,3-1,6
glucan), currently available commercially as a health food
supplement. Microbiol Immunol. 51:861–873. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Euhus DM, Hudd C, LaRegina MC and Johnson
FE: Tumor measurement in the nude mouse. J Surg Oncol. 31:229–234.
1986. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Tomayko MM and Reynolds CP: Determination
of subcutaneous tumor size in athymic (nude) mice. Cancer Chemother
Pharmacol. 24:148–154. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Smyth GK: Linear models and empirical
bayes methods for assessing differential expression in microarray
experiments. Stat Appl Genet Mol Biol. 3:Article 3. 2004.PubMed/NCBI
|
|
22.
|
Reiner A, Yekutieli D and Benjamini Y:
Identifying differentially expressed genes using false discovery
rate controlling procedures. Bioinformatics. 19:368–375. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Vetvicka V, Vashishta A, Saraswat-Ohri S
and Vetvickova J: Immunological effects of yeast- and
mushroom-derived beta-glucans. J Med Food. 11:615–622. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Löffler D, Brocke-Heidrich K, Pfeifer G,
Stocsits C, Hackermüller J, Kretzschmar AK, Burger R, Gramatzki M,
Blumert C, Bauer K, et al: Interleukin-6 dependent survival of
multiple myeloma cells involves the Stat3-mediated induction of
microRNA-21 through a highly conserved enhancer. Blood.
110:1330–1333. 2007.PubMed/NCBI
|
|
25.
|
Brock M, Trenkmann M, Gay RE, Michel BA,
Gay S, Fischler M, Ulrich S, Speich R and Huber LC: Interleukin-6
modulates the expression of the bone morphogenic protein receptor
type II through a novel STAT3-microRNA cluster 17/92 pathway. Circ
Res. 104:1184–1191. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Gomaa K, Kraus J, Rosskopf F, Röper H and
Franz G: Antitumour and immunological activity of a beta 1→3/1→6
glucan from Glomerella cingulata. J Cancer Res Clin Oncol.
118:136–140. 1992.
|
|
27.
|
Harnack U, Kellermann U and Pecher G:
Yeast-derived beta-(1-3),(1-6)-D-glucan induces up-regulation of
CD86 on dectin-1-positive human B-lymphoma cell lines. Anticancer
Res. 31:4195–4199. 2011.PubMed/NCBI
|
